flag
Search

News

Blogs & News

CycleGuard® 500 (melengestrol acetate) receives medicated feed combination approvals

CycleGuard® 500, a melengestrol acetate feed additive used for increased rate of weight gain, improved feed efficiency and suppression of estrus (heat) in heifers, has received U.S. Food & Drug Administration approval for combination use with other drug feed additive products in the manufacture of Type B and C medicated feeds.

Available as a Type A liquid medicated article from Huvepharma®, CycleGuard® 500 must be mixed with other feeds when fed, and should be fed according to label directions. The combination approvals, or Blue Bird labels, allow CycleGuard® 500 to also be used with other feed additives commonly fed to feedlot cattle to enhance rate of gain, feed efficiency, promote carcass leanness, and control coccidiosis, including monensin, tylosin and ractopamine hydrochloride and more.

The CycleGuard® 500 combinations receiving FDA approval include CycleGuard® 500 and Monovet® 90; CycleGuard, with Monovet® 90 and Optigrid® 45; CycleGuard, with Monovet® 90 and Tylovet® 100; CycleGuard with Monovet® 90, Tylovet® 100 and Optigrid® 45, as well as CycleGuard with Optigrid® 45 and Monovet® 90 plus and CycleGuard with Optigrid® 45, Monovet® 90 and Tylovet® 100.

“Huvepharma is focused on offering quality product choices and technical expertise to livestock producers and feeders to aid the industry in enhancing production and efficiency. CycleGuard® 500 used with these combination approvals provides one more tool available toward that effort,” said J. Free, director of U.S. Cattle Business for Huvepharma.

Huvepharma has offered animal health products for poultry, swine and cattle in the U.S. since 2005. In addition to CycleGuard® 500, over the past eighteen months the company has received FDA approvals for Monovet® 90, the first available bio-equivalent monensin, and Optigrid® 45, comprised of the active ingredient ractopamine hydrochloride.

In January 2021, Huvepharma also received FDA approval for four Blue Bird label combinations with Optigrid®45, a ractopamine hydrochloride Type A medicated article used increased rate of weight gain, improved feed efficiency and increased carcass leanness in cattle fed in confinement for slaughter. For more information, please contact your Huvepharma sales representative and/or Huvepharma’s Customer Service team at 877-994-4883, or visit www.huvepharma.us.

Huvepharma is a global pharmaceutical company with a focus on developing, manufacturing and marketing human and animal health products.  A privately-owned company headquartered in Sofia, Bulgaria, Huvepharma’s U.S. headquarter are located in Peachtree City, GA.  

 

 

 

 

 

 

IMPORTANT SAFETY INFORMATION: CYCLEGUARD® 500 (melengestrol acetate Type A liquid medicated article): Not effective in steers or spayed heifers.  Withdrawal periods of three to five days or more should be avoided to prevent the possibility that the heifers may come into estrus (heat) at loading time. When used in heifers intended for breeding, do not exceed 24 days. A reduced conception rate can be expected within 1 to 12 days after the withdrawal of melengestrol acetate. Heifers bred on subsequent observed estruses will have normal conception rates. To report adverse effects, access medical information, or obtain additional product information, call 1-877-426-7765. View product label here.

IMPORTANT SAFETY INFORMATION: TYLOVET® 100 (tylosin phosphate) TYPE A MEDICATED ARTICLE): Not for Human Use. For use in swine and beef cattle feeds only. Organisms may vary in their degree of susceptibility to any treatment. If no improvement is observed after the recommended treatment then a diagnosis and susceptibility should be reconfirmed.  To ensure adequate mixing, an intermediate blending step should be used prior to manufacturing a complete feed. Do not use in any liquid feed containing sodium metabisulfite or in any supplement, concentrate or complete feed containing in excess of 2% bentonite.  TYLOVET® 100 may be irritating to unprotected skin and eyes. When mixing and handling TYLOVET® 100 use protective clothing, impervious gloves, and a dust respirator. In case of accidental exposure, flush eyes with plenty of water. Exposed skin should be washed with plenty of soap and water. Remove and wash contaminated clothing. Seek medical attention if irritation becomes severe or persists. To report adverse effects, access medical information, or obtain additional product information call 1-877-426-7765. View product label here.

IMPORTANT SAFETY INFORMATION OPTIGRID® 45 (ractopamine hydrochloride Type A medicated article): Not for human use. For use in feeds for cattle fed in confinement for slaughter. Not for animals intended for breeding.  No withdrawal is necessary if directions are followed. The active ingredient in Optigrid 45, ractopamine hydrochloride, is a Beta-adrenergic agonist. Individuals with cardiovascular disease should exercise special caution to avoid exposure. Not for use in humans. Keep out of the reach of children. The Optigrid 45 formulation (Type A Medicated Article) poses a low dust potential under usual conditions of handling and mixing. When mixing and handling Optigrid 45 use protective clothing, impervious gloves, protective eye wear, and a NIOSH-approved dust mask. Operators should wash thoroughly with soap and water after handling. If accidental eye contact occurs, immediately rinse eyes thoroughly with water. If irritation persists, seek medical attention. The Safety Data Sheet (SDS) contains more detailed occupational safety information. For additional information about adverse drug experience reporting for animal drugs, contact FDA at 1-888-FDA-VETS or http://www.fda.gov/reportanimalae. To report suspected adverse drug events, for technical assistance or to obtain a copy of the SDS, contact Huvepharma, Inc. at 1-877-994-4883 or www.huvepharma.us. View product label here.

IMPORTANT SAFETY INFORMATION: MONOVET® 90 (monensin Type A medicated article): Not for Human Use.  Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Consumption by unapproved species may result in toxic reactions and even fatalities.  A withdrawal time has not been established for pre-ruminating calves.  Do not use in calves to be processed for veal.  When mixing and handling Monovet 90, use protective clothing, impervious gloves and a dust mask.  Operators should wash thoroughly with soap and water after handling.  If accidental eye contact occurs, immediately rinse with water.  To report adverse effects, access medical information, or obtain additional product information, call 1-877-426-7765. View product label here.